X

Quest & OncoCare to advance cancer therapy technology in the U.S.

Canadian biopharmaceutical company, Quest PharmaTech Inc., has reportedly announced its entry into a license agreement…

Ojaswita Kutepatil

Sysmex, MolecularMD partner for CDx development and commercialization

Japan’s in-vitro diagnostics company, Sysmex Corp. has recently announced a collaboration agreement with U.S. molecular…

Ojaswita Kutepatil

Roche acquires Jecure Therapeutics to develop liver disease drug

Roche, the Swiss drug manufacturer recently acquired the San Diego based startup Jecure Therapeutics for…

Shikha Sinha

Amazon offers software to read medical records and enhance treatments

Amazon is planning to sell a software which would read medical records and give out…

Shikha Sinha

US FDA approves new cancer fighting drug that targets genetic mutation

The U.S. Food & Drug Administration, a regulatory body that is a part of the…

Ojaswita Kutepatil

CVS Health to complete its $69 billion merger deal with Aetna

American retail and healthcare firms, CVS Health, and Aetna Inc. are currently in the final…

Ojaswita Kutepatil

Sun Pharma to buy Japanese company Pola Pharma in a $1 million deal

Renowned Indian multinational pharmaceutical giant Sun Pharmaceutical Industries Ltd. has reportedly announced that it has…

Shikha Sinha

Alembic Pharmaceuticals’ joint venture seeks approval for its new drug

An Indian multinational pharmaceutical company, Alembic Pharmaceuticals, has recently unveiled that its joint business undertaking…

Ojaswita Kutepatil

Eczema drug from Glenmark Pharma wins tentative approval from USFDA

Reports confirm that Glenmark Pharmaceuticals Inc., USA has announced that it has obtained a tentative…

Ojaswita Kutepatil